Magenta Therapeutics Stock Price To Earning
| MGTADelisted Stock | USD 0.82 0.03 3.80% |
Magenta Therapeutics fundamentals help investors to digest information that contributes to Magenta Therapeutics' financial success or failures. It also enables traders to predict the movement of Magenta Stock. The fundamental analysis module provides a way to measure Magenta Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Magenta Therapeutics stock.
Magenta |
Magenta Therapeutics Company Price To Earning Analysis
Magenta Therapeutics' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Magenta Therapeutics Price To Earning | (1.63) X |
Most of Magenta Therapeutics' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Magenta Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, Magenta Therapeutics has a Price To Earning of -1.6293 times. This is 106.31% lower than that of the Biotechnology sector and 133.05% lower than that of the Health Care industry. The price to earning for all United States stocks is 105.67% higher than that of the company.
Magenta Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Magenta Therapeutics' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Magenta Therapeutics could also be used in its relative valuation, which is a method of valuing Magenta Therapeutics by comparing valuation metrics of similar companies.Magenta Therapeutics is currently under evaluation in price to earning category among its peers.
Magenta Fundamentals
| Return On Equity | -0.65 | |||
| Return On Asset | -0.29 | |||
| Current Valuation | (32.66 M) | |||
| Shares Outstanding | 60.66 M | |||
| Shares Owned By Insiders | 2.23 % | |||
| Shares Owned By Institutions | 62.63 % | |||
| Number Of Shares Shorted | 383.03 K | |||
| Price To Earning | (1.63) X | |||
| Price To Book | 0.54 X | |||
| EBITDA | (78.98 M) | |||
| Net Income | (76.46 M) | |||
| Cash And Equivalents | 128.28 M | |||
| Cash Per Share | 2.13 X | |||
| Total Debt | 29.96 M | |||
| Debt To Equity | 0.25 % | |||
| Current Ratio | 10.22 X | |||
| Book Value Per Share | 1.24 X | |||
| Cash Flow From Operations | (67.09 M) | |||
| Short Ratio | 1.38 X | |||
| Earnings Per Share | (1.11) X | |||
| Target Price | 1.0 | |||
| Number Of Employees | 67 | |||
| Beta | 2.12 | |||
| Market Capitalization | 45.14 M | |||
| Total Asset | 146.65 M | |||
| Retained Earnings | (402.03 M) | |||
| Working Capital | 101.05 M | |||
| Current Asset | 33.34 M | |||
| Current Liabilities | 3.39 M | |||
| Z Score | -3.88 | |||
| Net Asset | 146.65 M |
About Magenta Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Magenta Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Magenta Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Magenta Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Magenta Stock
If you are still planning to invest in Magenta Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Magenta Therapeutics' history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |